Choose Language
Select a language for news translation.
BBH focuses on 25 biotech stocks causing higher volatility, while XPH holds 65 pharma companies for steadier returns; both charge 0.35% fees and yield 0.50%. B…
Written by Prosper Junior Bakiny for The Motley Fool -> Abivax's shares could rise even further as it advances a candidate poised to disrupt a large market. …
Amgen's dividend remains safe because its diversified drug portfolio and strong cash flow can absorb legal setbacks like the potential loss of Tavneos or Enbre…
Written by James Brumley for The Motley Fool -> CRISPR Therapeutics has developed a cutting-edge gene-editing biotechnology. Unlike many of its peers, CRISPR…
Scientists created a synthetic cell called SpudCell that mimics essential lifelike functions, offering a controlled platform to study cell behavior and develop…
Vertex Pharmaceuticals' stock hit a record high in 2024 after 17% growth, driven by long-term bets on new drugs like Casgevy and Journavx. The stock trades at …
Written by Andy Gould for The Motley Fool -> Fidelity MSCI Health Care Index ETF (FHLC) provides broad sector exposure with significantly lower fees than VanEc…
Thiel Capital’s Jack Selby leveraged Arizona ties to back startups like Etched while raising a $300 million second fund. This capital infusion strengthens the …
We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts . MapLight Therapeutics, Inc.
Legend Biotech and BioNTech are likely buyout targets due to their profitable therapies and strong pipelines. Their potential acquisitions matter because big p…
Early Bird pricing for TechCrunch Founder Summit 2026 ends tonight at 11:59 p.m. PT, with late registration costing up to $190 more. Networking with top founde…
